The patent for light-emitting nanoparticles will significantly advance CHOC’s research to develop non-invasive treatments for brain injuries.
CHOC is at the forefront to offer breakthrough enzyme replacement therapy to improve the quality of life for children with CLN2.
Dr. Autumn Ivy and her team study physical activity during periods of brain development that are highly sensitive to early-life experiences.
CHOC is at the forefront of bringing precise, advanced 3D brain imaging to neurologists and their patients.
Sumiko Abe uses her vast experience to help clinicians view the best possible images of the brain to influence treatment plans.
Developed by CHOC and UC Irvine, a new way to control pediatric seizures uses densely spaced electrodes to map high-frequency oscillations.